-65.7%
MRNA vs VIAV
+139.8%
-205.5%
-95.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | VIAV | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +3.6% | +1.8% | +4.7% |
| 7D | -1.1% | +11.2% | -12.2% | -3.2% |
| 30D | +126.1% | -10.1% | +136.2% | +128.9% |
| 3M | +190.0% | -22.9% | +212.9% | +198.3% |
| 6M | +157.2% | +28.8% | +128.4% | +106.9% |
| YTD | +388.2% | +117.5% | +270.7% | +199.3% |
| 1Y | +467.0% | +216.1% | +251.0% | +192.5% |
| 3Y | +36.1% | +292.2% | -256.1% | -39.0% |
| All | -65.7% | +139.8% | -205.5% | -79.4% |
Cumulative growth
Daily Returns
Daily percentage return beside VIAV.
Daily Out/Under-Performance
Portfolio return minus VIAV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VIAV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded VIAV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling